Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | RECQL | P46063 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | USP2 | O75604 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL407787 | 1.00 | SLC6A2 (0.57) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| SCHEMBL407788 | 1.00 | SLC6A2 (0.57) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| Hydrochloric Acid SCHEMBL28585467 | 0.98 | SLC6A2 (0.55) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| Hydrochloric Acid SCHEMBL28585466 | 0.98 | SLC6A2 (0.55) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| SCHEMBL7403762 | 0.93 | PLA2G10 (0.53) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| SCHEMBL8935465 | 0.93 | BLM (0.53) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| Hydrochloric Acid SCHEMBL27320071 | 0.87 | BLM (0.47) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| SCHEMBL9515271 | 0.86 | BLM (0.46) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| SCHEMBL122295 | 0.86 | BLM (0.72) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM | |
| SCHEMBL202327 | 0.86 | BLM (0.72) | SLC6A2TAAR1SMN1; SMN2HIF1ABLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220402983-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | JANSSEN BIOTECH, INC. | 2022-12-22 | — | — | US | claimed |
| JP-63123398-A | — | — | None | — | — | JP | disclosed |
| JP-63160599-A | — | — | None | — | — | JP | disclosed |
| JP-63157990-A | — | — | None | — | — | JP | disclosed |
| JP-57186495-A | — | — | None | — | — | JP | disclosed |
| WO-2010004535-A2 | THERAPEUTIC METHODS AND COMPOSITIONS EMPLOYING PEPTIDE COMPOUNDS | NYBERG FRED (SE) | 2010-01-14 | — | — | WO | disclosed |
| US-7241602-B2 | Nucleic acid sequences encoding enantioselective amidases | DSM IP ASSETS B.V. (NL) | 2007-07-10 | — | — | US | disclosed |
| EP-1409688-B1 | NUCLEIC ACID SEQUENCES ENCODING ENANTIOSELECTIVE AMIDASES | DSM IP ASSETS BV (NL) | 2007-06-20 | — | — | EP | disclosed |
| US-20050079595-A1 | Nucleic acid sequences encoding enantioselective amidases | DSM IP ASSETS B.V. (NL) | 2005-04-14 | — | — | US | disclosed |
| EP-1409688-A2 | NUCLEIC ACID SEQUENCES ENCODING ENANTIOSELECTIVE AMIDASES | DSM IP Assets B.V. (NL) | 2004-04-21 | — | — | EP | disclosed |
| EP-0838448-A1 | Process for the separation of a mixture of enantiomers | DSM N.V. (NL) | 1998-04-29 | — | — | EP | disclosed |
| EP-0668770-A4 | — | — | 1995-09-27 | — | — | EP | disclosed |
| EP-0668770-A1 | $g(a)-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1995-08-30 | — | — | EP | disclosed |
| WO-1994009031-A1 | ANALOGUES OF CHOLECYSTOKININ (30-33) CONTAINING AN ALPHA-SUBSTITUTED AMINOACID | WARNER-LAMBERT COMPANY (US) | 1994-04-28 | — | — | WO | disclosed |
| WO-1992019254-A1 | α-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1992-11-12 | — | — | WO | disclosed |
| JP-S63160599-A | PRODUCTION OF L-ALPHA-METHYLPHENYLALANINES | MITSUBISHI GAS CHEM CO INC | 1988-07-04 | — | — | JP | disclosed |
| JP-S63157990-A | PRODUCTION OF L-ALPHA-METHYLPHENYLALANINES | MITSUBISHI GAS CHEM CO INC | 1988-06-30 | — | — | JP | disclosed |
| JP-S63123398-A | PRODUCTION OF L-ALPHA-METHYLPHENYLALANINES | MITSUBISHI GAS CHEM CO INC | 1988-05-27 | — | — | JP | disclosed |
| JP-S57186495-A | PREPARATION OF L-ALPHA-METHYLPHENYLALANINE | UBE IND LTD | 1982-11-16 | — | — | JP | disclosed |
| EP-0001684-A2 | Tetrapeptides, methods for their preparation and their use in analgesic compositions | ELI LILLY AND COMPANY (US) | 1979-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220402983-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | IL23R, IL1RN, VIP | SLC6A2 4837/4885TAAR1 1981/4885SMN1; SMN2 4301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.